• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Practice Fusion Unveils EHR-Integrated Post-Marketing Active Safety Surveillance Program

by HITC Staff 02/15/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Practice Fusion

EHR provider  Practice Fusion has unveiled a first of its kind post-marketing active safety surveillance program within its EHR platform. The new active safety surveillance program can help facilitate Adverse Events of Special Interest (AESI) reporting by messaging healthcare providers directly at the point of care about AESIs their patients may have experienced during the course of therapy.

Post-Marketing Active Safety Surveillance Program Benefits

The post-marketing active safety surveillance program enables providers to monitor adverse events during the course of a patient’s treatment with prescription medications or other therapies. Using patient-level clinical characteristics, during a patient encounter, providers are notified through the Practice Fusion EHR when to screen patients for potential AESIs and how to facilitate AESI reporting following a patient encounter.

Rather than deploying a program to one medical practice at a time via the server-based model, Practice Fusion’s cloud-based model can rapidly integrate and deploy its active safety surveillance program to all practices using the company’s EHR. Practice Fusion’s connected digital health platform is used by over 30,000 practices — 6.4 percent of all practices in the U.S.1 — and has a separate de-identified clinical database, which includes over 38 million records containing rich clinical data.

“Our active safety surveillance program can be used to help satisfy important unmet needs for providers to more readily report AESIs at the point of care, for life sciences companies to work with providers to improve those companies’ post-market safety data collection, as well as for the U.S. Food and Drug Administration and the healthcare community to better understand the safety profile of approved therapeutics,” said Richard Loomis MD, Vice President and Chief Medical Officer at Practice Fusion.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: practice fusion

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |